India`s Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs

2025-05-22 06:01:36 pm | Source: reuters

India`s Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs

News By Tags | #StockMarket #PharmaSector #SunPharma

Sun Pharmaceutical, India's largest drugmaker by revenue, reported a rise in adjusted quarterly profit on Thursday, driven by strong domestic demand for its drugs to treat rare diseases.

The Mumbai-based firm's consolidated profit before exceptional items and tax rose 24% to 36.16 billion rupees ($420.7 million) in the three months ended March 31.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here

IGI Logo

India`s Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs

Top News

Tag News

More News